Publicacións (553) Publicacións de JUAN SANCHIS FORES

2024

  1. Analysis of myocardial infarction incidence and case-fatality in the last three decades in the province of Girona

    Revista Espanola de Cardiologia, Vol. 77, Núm. 6, pp. 450-458

  2. Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity

    Obesity Research and Clinical Practice

  3. Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes

    Revista Espanola de Cardiologia

  4. Catheter-directed therapy for acute pulmonary embolism: results of a multicenter national registry

    Revista Espanola de Cardiologia, Vol. 77, Núm. 2, pp. 138-147

  5. ChatGPT-4 versus human assessment in cardiology peer review

    Revista Espanola de Cardiologia

  6. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine

  7. Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal study

    European Journal of Heart Failure

  8. Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 167-176

  9. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689

  10. Impact of Epicardial Adipose Tissue on Infarct Size and Left Ventricular Systolic Function in Patients with Anterior ST-Segment Elevation Myocardial Infarction

    Diagnostics, Vol. 14, Núm. 4

  11. Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial

    ESC Heart Failure, Vol. 11, Núm. 2, pp. 1258-1262

  12. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

  13. Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 206-214

  14. Revista Española de Cardiología 2023

    Revista Espanola de Cardiologia, Vol. 77, Núm. 5, pp. 418-425

  15. Short-Course High-Intensity Statin Treatment during Admission for Myocardial Infarction and LDL-Cholesterol Reduction—Impact on Tailored Lipid-Lowering Therapy at Discharge

    Journal of Clinical Medicine, Vol. 13, Núm. 1

  16. Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure

    CardioRenal Medicine, Vol. 14, Núm. 1, pp. 261-269

  17. β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction

    JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396

2023

  1. A Software Tool for the Measurement of the Aortic Annulus Area by Means of Computed Tomography Image Analysis for the Planning of Transcatheter Aortic Valve Replacement (TAVR)

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, Vol. 2023, pp. 1-4

  2. Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  3. An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure

    Expert Review of Molecular Diagnostics, Vol. 23, Núm. 6, pp. 521-533